At the time of writing, Astrazeneca plc ADR [AZN] stock is trading at $68.05, up 1.51%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AZN shares have gain 2.48% over the last week, with a monthly amount drifted -4.72%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astrazeneca plc ADR [NASDAQ: AZN] stock has seen the most recent analyst activity on November 20, 2024, when UBS upgraded its rating to a Neutral. Previously, Deutsche Bank upgraded its rating to Hold on November 06, 2024. On September 13, 2024, downgrade downgraded it’s rating to Sell. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $97 on May 30, 2024. Deutsche Bank upgraded its rating to a Hold. Deutsche Bank downgraded its rating to Sell for this stock on February 08, 2024. In a note dated January 23, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $85 on this stock.
For the past year, the stock price of Astrazeneca plc ADR fluctuated between $60.47 and $87.68. Currently, Wall Street analysts expect the stock to reach $84 within the next 12 months. Astrazeneca plc ADR [NASDAQ: AZN] shares were valued at $68.05 at the most recent close of the market. An investor can expect a potential return of 23.44% based on the average AZN price forecast.
Analyzing the AZN fundamentals
According to Astrazeneca plc ADR [NASDAQ:AZN], the company’s sales were 51.21B for trailing twelve months, which represents an 18.04% jump. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.17 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 67.82 points at the first support level, and at 67.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 68.47, and for the 2nd resistance point, it is at 68.88.
Ratios To Look Out For
It is important to note that Astrazeneca plc ADR [NASDAQ:AZN] has a current ratio of 0.93. In addition, the Quick Ratio stands at 0.71 and the Cash Ratio stands at 0.19. Considering the valuation of this stock, the price to sales ratio is 4.12, the price to book ratio is 5.18 and price to earnings (TTM) ratio is 32.70.
